HeimTHYROCARE • NSE
add
Thyrocare Technologies Ltd
Við síðustu lokun
392,65 ₹
Dagbil
390,05 ₹ - 397,25 ₹
Árabil
236,05 ₹ - 536,67 ₹
Markaðsvirði
62,71 ma. INR
Meðalmagn
245,69 þ.
V/H-hlutf.
45,64
A/V-hlutfall
1,47%
Aðalkauphöll
NSE
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (INR) | des. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 1,96 ma. | 17,85% |
Rekstrarkostnaður | 763,70 m. | 25,20% |
Nettótekjur | 290,10 m. | 51,81% |
Hagnaðarhlutfall | 14,84 | 28,82% |
Hagnaður á hvern hlut | 2,11 | 78,20% |
EBITDA | 477,75 m. | 39,42% |
Virkt skatthlutfall | 20,74% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (INR) | des. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 1,92 ma. | 39,87% |
Heildareignir | — | — |
Heildarskuldir | — | — |
Eigið fé alls | 5,34 ma. | — |
Útistandandi hlutabréf | 159,16 m. | — |
Eiginfjárgengi | 11,69 | — |
Arðsemi eigna | — | — |
Ávöxtun eigin fjár | 16,20% | — |
Peningaflæði
Breyting á handbæru fé
| (INR) | des. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | 290,10 m. | 51,81% |
Handbært fé frá rekstri | — | — |
Reiðufé frá fjárfestingum | — | — |
Reiðufé frá fjármögnun | — | — |
Breyting á handbæru fé | — | — |
Frjálst peningaflæði | — | — |
Um
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East.
On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Stofnsett
1996
Höfuðstöðvar
Vefsvæði
Starfsfólk
1.822
